arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV

$4.76 ▲ +0.10 (+2.15%) at close

26 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

CLOVER HEALTH INVESTMENTS, CORP. /DE faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.5B

Dividend Yield —

Revenue Growth 62.0% ↗

Op. Margin 3.6% ↗

ROIC 6.4%

FCF / Share $0.20

Trailing P/E 95.2x

Price / Book 7.3x

FCF Yield 4.3%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$749.19M

↑ +62.0% —

Net Income Profit after all expenses

$27.33M

↑ +2245.5% —

Operating Margin Operating profit as % of sales

3.6%

↑ +136.1% 20th

FCF / Share Free cash flow per share

$0.20

↑ +821.1% —

Long-Term Debt Long-term obligations

$20.00M

— 0.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	62.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+676%)	44.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+459%)	50.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+526%)	34.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+326%)	33.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+316%)	—	-31.3% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-492%)	-30.6% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-483%)	-34.3% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-528%)	—	-43.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-647%)	-39.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-592%)	-39.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-596%)	—	100.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1157%)	105.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1216%)	336.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4106%)	159.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1899%)	152.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1808%)	139.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1646%)	21.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+163%)	—	—	—	—	—
EPS Growth YoY (%)	—	—	—	—	—	—	—	—	—	17.6% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	43.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	72.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	6.3% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	61.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-100.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	71.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	69.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	—	93.4% Excellent → Excellent Stable Year-over-year change in net income	93.4% Excellent ↑ Excellent Improving Year-over-year change in net income	93.4% Excellent ↑ Excellent Improving Year-over-year change in net income	—	73.6% Excellent → Excellent Stable Year-over-year change in net income	73.6% Excellent ↑ Excellent Improving Year-over-year change in net income	73.6% Excellent ↑ Excellent Improving Year-over-year change in net income	—	3.6% Caution → Caution Stable Year-over-year change in net income	3.6% Caution ↑ Caution Improving Year-over-year change in net income	3.6% Caution ↑ Caution Improving Year-over-year change in net income	—	-118.1% Weak ↓ Weak Declining Year-over-year change in net income	76.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-55.5% Weak Weak Year-over-year change in net income	-48.1% Weak Weak Year-over-year change in net income	N/M	N/M	-71.9% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	N/M	—	—	—	N/M	—	—	—	-68.1% Weak Weak Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	12.4% Good ↑ Good Improving Compound annual revenue growth over 3 years	—	-16.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-17.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-19.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-8.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-8.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-4.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	20.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	—	41.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	44.0% Excellent Excellent Compound annual revenue growth over 3 years	47.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	30.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	24.0% Excellent → Excellent Stable Compound annual revenue growth over 5 years	24.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	22.7% Excellent Excellent Compound annual revenue growth over 5 years	22.8% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	3.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-76%)	-10.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-167%)	-4.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-133%)	-2.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-115%)	-0.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-102%)	-6.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-142%)	-2.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-118%)	2.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-87%)	-6.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-144%)	—	-8.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-157%)	-5.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-137%)	-13.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-192%)	—	-8.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-158%)	-12.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-181%)	-10.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-167%)	-43.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-388%)	-34.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-333%)	-44.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-394%)	-59.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-496%)	-40.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-371%)	-12.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-185%)	13.5% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-10%)	-16.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-207%)	—
Profit Margin (%) (%)	3.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-70%)	—	-0.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-102%)	-0.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-102%)	-0.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-102%)	—	-5.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-148%)	-5.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-145%)	-5.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-146%)	—	-15.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-226%)	-14.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-218%)	-13.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-215%)	—	-8.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-173%)	-8.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-174%)	-8.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-172%)	-43.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-461%)	-8.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-167%)	-77.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-742%)	-24.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-301%)	-76.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-734%)	7.5% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-37%)	3.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-74%)	-17.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-242%)	—
FCF Margin (%) (%)	14.3% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-14.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	2.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	1.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-3.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-25.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	7.3% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	14.9% Fair Fair Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-6.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-18.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-46.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-36.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-20.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	7.6% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	-22.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	3.92x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	-8.96x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-3.80x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	12.93x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—	-1.33x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	-1.09x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.92x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-2.73x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.41x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	1.33x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	6.4% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	-17.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-14.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-27.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-43.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-15.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—
Return on Capital (%) (%)	3.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-0.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-3.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	—	-4.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-15.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-13.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	8.1% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-46%)	—	—	—	—	—	—	—	—	—	—	—	-22.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-250%)	—	-19.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-17.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-218%)	-15.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	—	-8.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-102.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-781%)	-8.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	—	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.05x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-91%)	0.05x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.04x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	—	0.05x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	0.04x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	-4115.29x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-182.96x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-262.94x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-216.63x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-463.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-361.39x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-147.98x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-101.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.48x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	2.73x Caution Caution Operating income divided by interest expense Optimal: > 5x	-3.41x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	—	$-78.30M	—	—	—	$-194.54M	$-287.96M	$-254.77M	$-208.25M	$-122.86M	$-299.01M	$-310.08M	$-190.56M	$-103.79M	$-362.87M	$-304.47M	$-253.83M	$-299.97M	$-182.34M	$-465.89M	$-380.22M	$-92.35M	—	—	$-112.49M	$0.00
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.27x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.20x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.23x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.13x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.20x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$1.43	—	$0.97	$0.94	$0.93	—	$0.68	$0.73	$0.71	—	$1.00	$1.07	$1.10	—	$1.79	$1.78	$1.85	—	$1.03	$1.01	—	—	$1.90	$1.94	—	—
Basic EPS, GAAP (USD)	$0.05	—	—	—	—	—	—	—	—	$-0.14	$-0.09	$-0.06	$-0.15	$-0.17	$-0.16	$-0.22	$-0.16	$-0.44	$-0.08	$-0.78	—	$-1.43	$0.06	$0.02	—	—
Free Cash Flow per Share (USD)	$0.20	—	$0.02	$0.01	$-0.03	—	—	—	$0.05	—	—	—	$0.16	—	—	—	$-0.12	—	—	—	—	—	$-0.39	$0.15	—	—
Book Value per Share (USD)	$0.65	—	—	—	—	—	—	—	—	—	—	—	$0.67	—	$0.82	$0.90	$1.04	—	$0.99	$0.76	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.65	—	—	—	—	—	—	—	—	—	—	—	$0.67	—	$0.82	$0.90	$1.04	—	$0.99	$0.76	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	522.18M	—	512.74M	509.04M	497.06M	—	490.18M	487.48M	486.37M	—	480.77M	479.16M	478.81M	—	477.69M	476.06M	473.03M	—	414.57M	408.16M	—	—	88.86M	88.61M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$111.44M	$99.03M	$137.47M	$160.99M	$115.76M	$129.61M	$153.09M	$225.06M	$196.35M	$166.85M	$197.00M	$221.17M	$163.88M	$193.49M	$331.65M	$262.38M	$339.39M	—	$329.03M	$521.82M	$636.42M	—	—	—	—	$-117.98K
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$20.00M	$20.00M	$20.00M	—	$19.93M	$19.85M	$24.29M	—	—	—	—	—
Total Equity (USD)	$339.43M	—	—	—	—	—	—	—	—	—	—	—	$323.11M	—	$391.98M	$426.92M	$489.81M	—	$408.39M	$310.95M	$585.03M	—	—	—	—	$0.00

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$749.19M	$487.71M	$496.65M	$477.62M	$462.33M	$336.96M	$330.99M	$356.26M	$346.92M	—	$482.07M	$513.63M	$527.77M	—	$856.82M	$846.70M	$874.38M	$432.04M	$427.16M	$412.47M	$200.32M	$166.23M	$169.07M	$172.08M	$165.50M	—
Net Income, GAAP (USD)	$27.33M	—	$-1.27M	$-1.27M	$-1.27M	—	$-19.17M	$-19.17M	$-19.17M	—	$-72.61M	$-72.61M	$-72.61M	—	$-75.31M	$-75.31M	$-75.31M	$-187.20M	$-34.53M	$-317.61M	$-48.42M	$-126.39M	$12.76M	$5.40M	$-28.16M	—
Operating Cash Flow (USD)	$107.89M	$-68.15M	$12.10M	$5.41M	$-16.29M	$-85.83M	—	—	$25.93M	—	—	—	$79.03M	—	—	—	$-57.04M	$-80.18M	—	—	$-92.87M	$-59.90M	$-34.65M	$13.23M	$-37.18M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

CLOVER HEALTH INVESTMENTS, CORP. /DE

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CLOV with peers